Home » Topics » Regulatory

Regulatory
RSS

Additional indication for Actos approved in Japan

March 26, 2009

Fablyn approved in Europe for the treatment of osteoporosis

March 26, 2009

FDA approves Symbyax for treatment-resistant depression

March 24, 2009

Dainippon launches Trerief in Japan for Parkinson's disease

March 16, 2009

FDA approves expanded indication for peginterferon-based combination therapy

March 13, 2009

Mepact receives E.U. approval for non-metastatic resectable osteosarcoma

March 11, 2009

Menarini launches CV Therapeutics' Ranexa in the U.K. and Germany

March 5, 2009

Sanofi pasteur's intradermal microinjection influenza vaccine approved in E.U.

Feb. 26, 2009

Valdoxan approved for the treatment of major depressive episodes in Europe

Feb. 26, 2009

European Commission approves Efient for acute coronary syndrome

Feb. 24, 2009

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...